Rhenovia Pharma

Rhenovia Pharma nabs $738K in Series B round

Rhenovia Pharma, biotechnology company that specializes in applying biosimulation in researching and developing new therapies, has secured $738,000 or €540,000 for its second financing round.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics